4//SEC Filing
DERMA SCIENCES, INC. 4
Accession 0001144204-17-011044
CIK 0000892160operating
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 5:38 PM ET
Size
9.5 KB
Accession
0001144204-17-011044
Insider Transaction Report
Form 4
NAVARRO SAMUEL E
Director
Transactions
- Disposition to Issuer
Restricted Stock Units
2017-02-24−25,000→ 0 total→ Common Stock (25,000 underlying) - Disposition to Issuer
Common Stock
2017-02-24−37,500→ 0 total - Disposition to Issuer
Common Stock
2017-02-24+25,000→ 25,000 total
Footnotes (4)
- [F1]Pursuant to the terms of the Agreement and Plan of Merger, dated January 10, 2017, by and among the Issuer, Integra Derma, Inc. and Integra LifeSciences Holdings Corporation (the "Merger Agreement"), as of the Effective Time (as defined in the Merger Agreement), the shares of the Issuer's common stock were converted into the right to receive $7.00 per share to the reporting person in cash.
- [F2]Represents shares of the Issuer's common stock received upon the vesting of 25,000 restricted stock units, as described herein.
- [F3]Upon the Effective Time, and in connection with a tender offer pursuant to which Integra Derma, Inc. offered to purchase all of the Issuer's common stock for $7.00 per share, the restricted stock units were converted into the right to receive an amount in cash equal to $7.00 with respect to each share of common stock underlying such award, payable without any interest thereon and subject to any required tax withholdings.
- [F4]The restricted stock units were originally granted in consideration of the reporting person's services to the Issuer and without payment of consideration.
Documents
Issuer
DERMA SCIENCES, INC.
CIK 0000892160
Entity typeoperating
IncorporatedPA
Related Parties
1- filerCIK 0000892160
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 5:38 PM ET
- Size
- 9.5 KB